Clinical Trial Update: Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating omega-3 fatty acids as adjunctive therapy for stimulants in children with ADHD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Antonios Likourezos | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: TERMINATED